Future Tech & AI Wonders · Alex Turner · 21 November 2026

Court approves $7.25bn Roundup settlement over cancer claims

Court approves $7.25bn Roundup settlement over cancer claims

A Missouri court on Friday approved Bayer’s $7.25 billion settlement over claims that Roundup caused non-Hodgkin lymphoma. Judge Timothy Boyer called the nationwide deal fair, reasonable, and adequate for current and future claimants. Bayer denies the weedkiller causes cancer and will make annual fund payments for up to 21 years.

Key Takeaways

What did the court decide about the Roundup settlement?

Judge Timothy Boyer approved the proposed $7.25 billion (£5.5bn) nationwide settlement on Friday, saying it was “fair, reasonable, and adequate.” The decision clears a path for payouts after years of U.S. lawsuits alleging Bayer’s Roundup weedkiller caused cancer.

Some attorneys objected that the settlement funds were not enough. The judge said he did not want to delay money reaching sick victims. Coverage of the ruling is also tracked in our Future Tech & AI Wonders hub for readers following major corporate and product disputes.

Who can receive money from the Bayer deal?

According to reporting by the BBC, the settlement will pay Roundup users who already have non-Hodgkin lymphoma and those who fall ill in the future. Bayer will make annual payments into a fund for up to 21 years, providing as much as $7.25 billion.

Participant awards are expected to range from $10,000 to $165,000. Amounts depend on how frequently people used the product, when they were diagnosed, and how severe their illness was.

Why does Bayer still deny Roundup causes cancer?

Bayer continues to deny that Roundup causes cancer, even as it funds the deal to resolve a sprawling U.S. legal fight. The German biotech company had already paid roughly $10 billion to settle related Roundup litigation.

Roundup was developed by Monsanto in the 1970s. In 2015, the International Agency for Research on Cancer, a World Health Organization unit, identified its active ingredient glyphosate as a probable human carcinogen. Bayer and some regulators, including the U.S. Environmental Protection Agency, have disputed those findings.

How does this fit with earlier Roundup court rulings?

The settlement follows a June U.S. Supreme Court decision that favored Bayer. The court ruled 7-2 that Bayer cannot be sued in state courts over a failure-to-warn theory because federal regulations do not mandate a cancer warning label. That ruling overturned a $1.25 million award for a Missouri man who blamed Roundup and glyphosate for his non-Hodgkin lymphoma.

Bayer has faced thousands of claims in U.S. state and federal courts from people who say they developed cancer after using the product. Juries in several states have awarded large sums, keeping the litigation costly for years. Friday’s court approval aims to put a long-term claims program around both present and future cases.

← Open in blast feed